173 related articles for article (PubMed ID: 2830625)
1. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.
Kenney S; Kamine J; Markovitz D; Fenrick R; Pagano J
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1652-6. PubMed ID: 2830625
[TBL] [Abstract][Full Text] [Related]
2. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.
Davis MG; Kenney SC; Kamine J; Pagano JS; Huang ES
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8642-6. PubMed ID: 2825201
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.
Kenney S; Kamine J; Holley-Guthrie E; Mar EC; Lin JC; Markovitz D; Pagano J
J Virol; 1989 Sep; 63(9):3870-7. PubMed ID: 2548002
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.
Kenney S; Kamine J; Holley-Guthrie E; Lin JC; Mar EC; Pagano J
J Virol; 1989 Apr; 63(4):1729-36. PubMed ID: 2538653
[TBL] [Abstract][Full Text] [Related]
5. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
Kao SY; Calman AF; Luciw PA; Peterlin BM
Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
[TBL] [Abstract][Full Text] [Related]
6. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
Zhang L; Chiu J; Lin JC
DNA Cell Biol; 1998 Sep; 17(9):735-42. PubMed ID: 9778032
[TBL] [Abstract][Full Text] [Related]
7. Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression.
Oguro MO; Shimizu N; Ono Y; Takada K
J Virol; 1987 Oct; 61(10):3310-3. PubMed ID: 3041051
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
9. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.
Quinlivan EB; Holley-Guthrie E; Mar EC; Smith MS; Kenney S
J Virol; 1990 Apr; 64(4):1817-20. PubMed ID: 2157062
[TBL] [Abstract][Full Text] [Related]
11. Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein.
Lieberman PM; O'Hare P; Hayward GS; Hayward SD
J Virol; 1986 Oct; 60(1):140-8. PubMed ID: 3018281
[TBL] [Abstract][Full Text] [Related]
12. Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR.
Markovitz DM; Kenney S; Kamine J; Smith MS; Davis M; Huang ES; Rosen C; Pagano JS
Virology; 1989 Dec; 173(2):750-4. PubMed ID: 2556854
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions.
Lieberman PM; Hardwick JM; Hayward SD
J Virol; 1989 Jul; 63(7):3040-50. PubMed ID: 2542612
[TBL] [Abstract][Full Text] [Related]
14. A quantitative bioassay for HIV-1 based on trans-activation.
Felber BK; Pavlakis GN
Science; 1988 Jan; 239(4836):184-7. PubMed ID: 3422113
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.
Kashanchi F; Wood C
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391
[TBL] [Abstract][Full Text] [Related]
16. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.
Mosca JD; Bednarik DP; Raj NB; Rosen CA; Sodroski JG; Haseltine WA; Hayward GS; Pitha PM
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7408-12. PubMed ID: 2823260
[TBL] [Abstract][Full Text] [Related]
17. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.
Chavrier P; Gruffat H; Chevallier-Greco A; Buisson M; Sergeant A
J Virol; 1989 Feb; 63(2):607-14. PubMed ID: 2536096
[TBL] [Abstract][Full Text] [Related]
20. Conservation of sequence and function between the product of the 52-kilodalton immediate-early gene of herpesvirus saimiri and the BMLF1-encoded transcriptional effector (EB2) of Epstein-Barr virus.
Nicholas J; Gompels UA; Craxton MA; Honess RW
J Virol; 1988 Sep; 62(9):3250-7. PubMed ID: 2841477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
